Skip to main content
. 2022 Mar 21;45(4):319–331. doi: 10.1007/s40264-022-01151-w

Table 5.

Reported AESI per vaccine (MedDRA preferred terms)

AESI AstraZeneca Pfizer Moderna Janssen
COVID-19 infection 17 3 0 1
Hypersensitivity 9 8 1 0
Arrhythmia 6 7 1 0
Epilepsy 2 1 2 0
Facial paralysis 1 0 1 0
Hypersomnia 1 0 1 0
Myocardial infarction 0 2 0 0
Product administration error 1 0 0 1
Pulmonary embolism 2 0 0 0
Acute myocardial infarction 1 0 0 0
Anaphylactic reaction 0 0 0 1
Atrioventricular block complete 0 1 0 0
Cerebrovascular accident 0 1 0 0
Facial paresis 1 0 0 0
Myocarditis 0 1 0 0
Pericarditis 0 1 0 0
Petit mal epilepsy 0 1 0 0
Platelet count decreased 0 0 1 0
Respiratory arrest 1 0 0 0
Seizure 0 1 0 0
Thrombosis 1 0 0 0
Vasculitis 1 0 0 0
Total 44 27 7 3

AESI adverse events of special interest